$11.67
$19.78
bear $11.67
base $14.16
bull $19.78
margin of safety $10.50
market price* $16.46
What the company is today. Tiptree spent the last decade as a holding company whose value was almost entirely Fortegra, a specialty insurer it bought in December 2014 for about $212 million. On May 29, 2026 it sold Fortegra to DB Insurance of Korea for $1.65 billion, of which about $1.12 billion came to Tiptree (the rest went to Warburg Pincus, a minority investor since 2022). It also sold its mortgage lender, Reliance First Capital, on May 1, 2026 for about $50 million, at 93.5% of that business's tangible book value. As of June 30, 2026 Tiptree has no operating revenue and no debt (its $75 million credit line was repaid at closing). It holds about $947 million of cash and $158 million of marketable securities, owes about $205 million of income tax on the sale, and has shareholders' equity of $907 million, about $23.86 per diluted share. On July 28, 2026 it agreed to buy Universal Shield Insurance Group, an Ohio-based commercial property and casualty insurer licensed in 49 states, for $100 million plus further capital, with closing expected in the first quarter of 2027. Management says it wants to use the rest of the money for more acquisitions in insurance, asset management and specialty finance, alongside a $0.06 quarterly dividend and a $20 million buyback authorization. How we valued it. Because Fortegra is gone, the company's own ten-year earnings record describes a business Tiptree no longer owns, so we did not use it. What remains is the head office. On the restated figures for the business that remains, it used about $34 million to $42 million a year of cash from 2023 through 2025, counting stock compensation as a real cost. In the first half of 2026 employee pay and other costs ran at about $35 million a year before tax, or about $27 million after tax (roughly $0.70 per share). The company's own annual report names bringing these costs into line with its smaller size as a risk. Meanwhile, cash in Treasury bills earns about 3.7% before tax (about 2.85% after tax), which only roughly covers those costs. So the value of each share depends on three things: how much of the $23.86 of net assets the head office uses up, how well the cash is invested, and when shareholders get it back. We discount at 6%. Cash that earns less than that and stays inside the company is worth less than its face value to an owner. Base case, about $14.16 per share. Universal Shield closes as agreed. We assume about $150 million goes into it and earns a normal after-tax 6% on the price paid, since no figures for its earnings have been published. The remaining roughly $750 million stays in Treasuries: no other deal is signed, and we do not count acquisitions that have not happened. Head-office costs stay at the current rate, and the dividend continues. By year ten, net assets are roughly where they started, about $845 million. We value them at face value then, because they are mostly cash and business stakes bought at a fair price. Most of the gap between this value and today's net assets comes from ten years of cash earning less than 6% while the head office costs roughly what the cash earns. Bear case, about $11.67 per share. Head-office costs return to the $40 million pre-tax level of 2023 to 2025. About $500 million is spent on acquisitions over three years that earn only about 3% after tax. We see this as the realistic downside, not a worst imaginable case, because Tiptree's record outside Fortegra is mixed: it exited its senior-living, shipping and mortgage ventures, and the mortgage business sold below tangible book. The company also has to keep non-cash investments below about 40% of assets to stay outside investment-company rules, which pushes it toward buying operating businesses rather than waiting. In year ten, the acquired businesses sell for 85% of their carrying value. What protects the downside is that most of the balance sheet is cash and there is no debt, so even this case is far from zero. Bull case, about $19.78 per share. Universal Shield closes, and about $500 million in total goes into specialty insurance within two years. It earns about 8% after tax on the price paid, the kind of return Tiptree achieved with Fortegra. Because those businesses earn more than 6%, they are worth about a third more than their cost by year ten, in line with the large gain Tiptree made on Fortegra. We did not assume lower head-office costs or any repeat of a Fortegra-sized result. That result came from a single concentrated bet, not a repeatable process, so we do not count it as dependable growth. What we did not count. Management's plan to deploy the full amount, any sale of Universal Shield at a premium, and any cut in overhead are hopes, not signed facts, so none of them enter the base case. Senior managers hold about 4.5 million performance share units that vest only if the share price reaches targets starting near $28.83 and rising to $70. Those units dilute shareholders only in outcomes above our bull case. Universal Shield's premiums, profits and capital have not been disclosed, so its contribution cannot be checked yet. What would make this wrong. The value would be higher if Tiptree returned a large part of the cash, cut head-office costs, or invested at Fortegra-like returns. It would be lower if it paid too much for acquisitions or let costs grow. The margin-of-safety price sits well below the bear case: at that level the shares would be priced at less than about half of the cash-backed net assets.